Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Min Kyong Moon"'
Publikováno v:
Endocrinology and Metabolism, Vol 36, Iss 4, Pp 885-894 (2021)
Endocrinology and Metabolism
Endocrinology and Metabolism
Background: There has been controversy regarding the association between primary aldosteronism (PA) and dyslipidemia and few studies considered the effects of diabetes and renal function on lipid metabolism. We analyzed lipid profiles of PA patients
Autor:
Ju-Young Moon, Seung Hyun Ko, Jong Ha Baek, Tae Jung Oh, Min Kyong Moon, Kyu Yeon Hur, Hyun Jung Kim, Dongwon Lee, Tae Hee Kim
Publikováno v:
The Journal of Korean Diabetes. 21:105-115
Autor:
Min Kyong Moon, Kun Ho Yoon, Young Hye You, Seung Hyun Ko, Ji-Won Kim, Ye Jee Lee, Yu Bae Ahn
Publikováno v:
Journal of Cellular Biochemistry. 120:8534-8546
Objective We investigated the effects of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes (T2DM). Methods Empagliflozin (OLETF-EMPA) or voglib
Autor:
Yongjun Cha, Keun Seok Lee, Sung Hoon Sim, Ji Yeon Baek, Seung Chul Heo, Sujeong Go, You Jin Lee, Sun-Young Kim, In Hae Park, Jungnam Joo, Min Kyong Moon, Eun Kyung Lee, Yul Hwangbo, Hyewon Lee, Bo-Kyung Koo
Publikováno v:
Diabetes research and clinical practice. 174
Aims To investigate the incidence of and risk factors for new-onset type 2 diabetes mellitus (DM) developed during chemotherapy that included steroids in cancer patients without DM. Methods This multicenter, prospective, and observational cohort stud
Autor:
Gi Jeong Cheon, Ji Young Yoo, Young Min Kwon, Sunmi Kim, Young Joo Park, Kyungho Choi, Min Kyong Moon, Yoon Hee Cho, Jeongim Park, Sohyeon Choi, Inae Lee, Min Joo Kim
Publikováno v:
The Science of the total environment. 762
Air pollution and fuel emissions are the common sources of human exposure to polycyclic aromatic hydrocarbons (PAHs) and heavy metals. Several studies have suggested potential associations between PAHs/heavy metals and thyroid hormones, however, repo
Autor:
Moon-Kyu Lee, Mi-Kyung Kim, Eun Sook Kim, Gyuri Kim, Soo Lim, Kyu Jeung Ahn, Hye Soon Kim, Ie Byung Park, Sin Gon Kim, Min Kyong Moon, Chang Beom Lee, Tae Ho Kim, Seok Won Park, Hyuk-Sang Kwon, Kang Seo Park, Su Kyoung Kwon, Choon Hee Chung, Dong Jin Chung, Cheol-Young Park
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To investigate the efficacy and safety of evogliptin compared with linagliptin in patients with type 2 diabetes. Materials and Methods In this 12‐week, multicentre, randomized, double‐blind, active‐controlled, and 12‐week open‐label ext
Autor:
Moon Kyu Lee, Juan Pablo Frias, Sang Youl Rhee, Elaine Watkins, Sin Gon Kim, Byung Joon Kim, Hyeong Kyu Park, Frank L. Greenway, Bradley Block, Bong Soo Cha, Seung-Hwan Lee, Choon Hee Chung, Min Kyong Moon
Publikováno v:
Journal of diabetes and its complications. 34(5)
Aim MLR-1023, called Tolimidone when evaluated unsuccessfully by Pfizer for gastric ulcer disease, has been repurposed as a novel oral insulin sensitizer with its effects mediated by selective activation of Lyn kinase. We aimed to evaluate the optima
Autor:
Seok O Park, Kyung Mook Choi, Min Kyong Moon, Hyun-Jin Kim, Nan Hee Kim, Seung Hyun Ko, Kyu Yeon Hur, Sang Youl Rhee, Byung Wan Lee, Jin Hwa Kim
Publikováno v:
The Korean Journal of Internal Medicine
Diabetes & Metabolism Journal
Diabetes & Metabolism Journal, Vol 41, Iss 5, Pp 337-348 (2017)
Diabetes & Metabolism Journal
Diabetes & Metabolism Journal, Vol 41, Iss 5, Pp 337-348 (2017)
In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last upd
Autor:
Sam Kwon, Min Kyong Moon, Kun-Ho Yoon, Soo Lim, Eun Sook Kim, Eun Young Kim, Sung-Ho Kim, Kyung Ah Han, Mi-Kyung Kim, Jaemyung Yu, Dong-Jun Kim, Kwan Woo Lee, Moon-Kyu Lee, Manaj Wongtanate, Parinya Chamnan
Publikováno v:
Diabetes, Obesity & Metabolism
Background Gemigliptin is a new dipeptidyl peptidase-IV inhibitor. We investigated the efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes (T2D)
Autor:
Soowon Park, Seong A. Shin, Dong Hyun Yoon, Bo Kyung Koo, Jun-Young Lee, Jihyeon Kim, Hongrae Kim, Ji Yeon Lee, Min Kyong Moon, Yu Kyeong Kim
Publikováno v:
Journal of Clinical Medicine
Volume 7
Issue 11
Journal of Clinical Medicine, Vol 7, Iss 11, p 413 (2018)
Volume 7
Issue 11
Journal of Clinical Medicine, Vol 7, Iss 11, p 413 (2018)
Background: It is controversial whether exposure to insulin resistance accelerates cognitive deterioration. The present study aimed to investigate the association between insulin resistance and gray matter volume loss to predict the cognitive decline